Benj Gallander Migenix Inc. MGI-T BUY Sep 06, 2005

Works in the field of acne and hepatitis and they are certainly making progress, but will need more money to do it. Have some government support now.

Benj Gallander

Owned

Unlock Rating

$0.450

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

STRONG BUY

A very good buy at this price and in a good space. Prospects are very good. Can't go wrong

TOP PICK

Holds this one personally.Risky

PAST TOP PICK

(A Top Pick June 14/04. Down 34%.) Work in the alzheimer nad hepatitis regions. Has dropped because they want to issue more shares. Have a lot of cash.

HOLD

(Market Call Minute.) You have to have a lot of guts right now to buy this.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Benj Gallander Migenix Inc. MGI-T BUY Sep 06, 2005

You might be interested:

Migenix Inc.(MGI-T)

Migenix Inc.(MGI-T)

Migenix Inc.(MGI-T)

Migenix Inc.(MGI-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights